DE3682215D1 - Organische verbindungen und ihre pharmazeutische verwendung. - Google Patents

Organische verbindungen und ihre pharmazeutische verwendung.

Info

Publication number
DE3682215D1
DE3682215D1 DE8686300598T DE3682215T DE3682215D1 DE 3682215 D1 DE3682215 D1 DE 3682215D1 DE 8686300598 T DE8686300598 T DE 8686300598T DE 3682215 T DE3682215 T DE 3682215T DE 3682215 D1 DE3682215 D1 DE 3682215D1
Authority
DE
Germany
Prior art keywords
sub
sup
organic compounds
pharmaceutical use
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686300598T
Other languages
English (en)
Inventor
Stephen Richard Baker
William James Ross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilly Industries Ltd
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Application granted granted Critical
Publication of DE3682215D1 publication Critical patent/DE3682215D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE8686300598T 1985-01-30 1986-01-29 Organische verbindungen und ihre pharmazeutische verwendung. Expired - Fee Related DE3682215D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858502258A GB8502258D0 (en) 1985-01-30 1985-01-30 Organic compounds

Publications (1)

Publication Number Publication Date
DE3682215D1 true DE3682215D1 (de) 1991-12-05

Family

ID=10573633

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686300598T Expired - Fee Related DE3682215D1 (de) 1985-01-30 1986-01-29 Organische verbindungen und ihre pharmazeutische verwendung.

Country Status (7)

Country Link
US (1) US4675335A (de)
EP (1) EP0190042B1 (de)
JP (1) JPS61210066A (de)
AT (1) ATE69050T1 (de)
CA (1) CA1281331C (de)
DE (1) DE3682215D1 (de)
GB (2) GB8502258D0 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143931A (en) * 1982-06-24 1992-09-01 Smithkline Beecham Corporation Leukotriene antagonists containing tetrazolyl groups
US4939279A (en) * 1985-04-19 1990-07-03 Smithkline Beecham Corporation Leukotriene antagonists
GB8530222D0 (en) * 1985-12-07 1986-01-15 Lilly Industries Ltd Organic compounds
GB8709547D0 (en) * 1987-04-22 1987-05-28 Lilly Industries Ltd Organic compounds
GB8709546D0 (en) * 1987-04-22 1987-05-28 Lilly Industries Ltd Pharmaceutical use of organic compounds
PT87616B (pt) * 1987-06-24 1992-09-30 Smithkline Beecham Corp Processo de preparacao de antagonistas do leucotrieno e de composicoes farmaceuticas
GB8725260D0 (en) * 1987-10-28 1987-12-02 Lilly Industries Ltd Organic compounds
GB8807016D0 (en) * 1988-03-24 1988-04-27 Lilly Industries Ltd Organic compounds & their pharmaceutical use
EP0360246B1 (de) * 1988-09-21 1994-03-30 G.D. Searle & Co. 3-Oxiranbenzoesäuren und Derivate
US4954513A (en) * 1988-12-23 1990-09-04 Smithkline Beecham Corporation Leukotriene antagonists
US5239082A (en) * 1992-08-03 1993-08-24 Warner-Lambert Company Sulfonamide tetrazole ACAT inhibitors
ZA945190B (en) * 1993-07-30 1995-02-24 Kotobuki Seiyaku Co Ltd Carboxymethylidenecycloheptimidazole derivatives method or manufacturing the same and therapeutic agents containing these compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513005A (en) * 1981-06-18 1985-04-23 Lilly Industries Limited SRS-A antagonists
EP0123543B1 (de) * 1983-04-21 1988-02-03 Merck Frosst Canada Inc. Leukotrienantagonisten, deren Herstellung und Verwendung sowie diese enthaltende Zusammensetzungen
GB8320943D0 (en) * 1983-08-03 1983-09-07 Lilly Industries Ltd Organic compounds

Also Published As

Publication number Publication date
EP0190042B1 (de) 1991-10-30
ATE69050T1 (de) 1991-11-15
EP0190042A3 (en) 1988-02-24
GB2170204A (en) 1986-07-30
US4675335A (en) 1987-06-23
EP0190042A2 (de) 1986-08-06
JPS61210066A (ja) 1986-09-18
GB8602116D0 (en) 1986-03-05
CA1281331C (en) 1991-03-12
GB2170204B (en) 1988-10-12
GB8502258D0 (en) 1985-02-27

Similar Documents

Publication Publication Date Title
DE3587126D1 (de) Carbapenem-derivate und sie enthaltende zusammensetzung.
DE69108138T2 (de) Imidazopyridinderivate und ihre Verwendung.
NO901392D0 (no) Immunomodulerende azaspiraner.
ES2137915T3 (es) Derivados de tiazolidindiona sustituida.
ATE117681T1 (de) Chinolinderivate, ihre herstellung und verwendung.
ATE87621T1 (de) Antikrebs-chinazolinon-derivate.
DE3682215D1 (de) Organische verbindungen und ihre pharmazeutische verwendung.
DK165109C (da) 4-anilino-cyklopentaoedaapyrimidinderivater samt farmaceutiske midler indeholdende saadanne
DK5386A (da) Arylcyklobutylaminer og laegemiddelpraeparat indeholdende en saadan forbindelse
ES557663A0 (es) Un procedimiento para la sintesis de derivados de imidazol.
DE69614833T2 (de) Entzündungshemmende benzoesäurederivate
MX170732B (es) Composicion de derivados de succinimida y su uso
ATE56443T1 (de) Tetrazolylderivate und ihre pharmazeutische verwendung.
ATE38675T1 (de) Phosphatesterderivate und ihre verwendung als anti-krebsmittel.
SE8303913D0 (sv) Heterocykliska foreningar
DE3682599D1 (de) 1-oxa-1-dethia-cephalosporinverbindungen und sie enthaltendes antibakterielles mittel.
ATE65986T1 (de) Propanolabkoemmlinge.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee